© 2021 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2021 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
May 29, 2018
The science behind immunotherapy and gastrointestinal cancers is not quite perfected yet, but one subset of patients is seeing remarkable results.
‘Promising Times’ for Patients With CLL
PARP Inhibitors Help Ovarian Cancer Survivors Live Longer – and Better – Without Disease Progression
When Cancer Becomes a Liability in the Relationship
FDA Approves Tecentriq for Pretreated NSCLC